https://www.selleckchem.com/products/CHIR-258.html
61 [1.92-6.79]) compared to non-PTC group. However, the risk of mortality was not different between the PTC and non-PTC groups. According to the cancer type, only urogenital cancer had a significant association with graft failure (adjusted HR, 4.26 [1.19-15.22]) and the gastrointestinal cancer showed elevated risk of T cell mediated rejection compared to non-PTC (adjusted HR, 20.44 [6.02-69.39]). Conclusion Appropriate monitoring of graft function is necessary in patients with cured PTCs.Background Since the recently announced Communit
Like
Comment
Share
